06-Nov-2019: The Europe hyaluronic acid
based dermal fillers market size is expected to reach
USD 1.4 billion by 2026, according to a new report by Grand View Research Inc.,
exhibiting a CAGR of 7.6% over the forecast period. Rapidly aging population,
large number of cosmetic surgeries performed, and technological advancements
are among key factors driving the market. Growing demand to enhance one’s
aesthetic appeal is resulting in high number of cosmetic surgeries being
performed. This can also be attributed to the availability of noninvasive
surgical alternatives and rising awareness among consumers. According to the
International Society of Aesthetic Plastic Surgery (ISAPS), in 2017, hyaluronic
acid-based dermal filler procedures were among the three most preferred noninvasive
aesthetic surgeries.
Minimal adverse
effects, lesser pain, shorter recovery time, and fewer postsurgical
complications are some of the factors driving preference for minimally invasive
surgeries. The European market is dominated by well-known brands such as
Juvederm, Restylane, and Belotero. In addition, France has several native
brands with different patented technologies, thereby contributing to regional
market growth. Stylage, Cytosial, Hyaluronica, and Surface Volume are some of
the local brands available in the market.
Increasing demand
for aesthetic procedures majorly in Italy and Spain is creating a great
opportunity for market expansion. According to the ISAPS, about 952,830
aesthetic surgeries were performed in 2016, of which 650,995 were noninvasive
procedures such as Botox and dermal fillers.
Various strategic
initiatives such as product launch, approvals, and mergers and acquisitions
propel the market. For instance, in January 2017, Allergan plc launched
Juvederm VOLITE, a new hyaluronic acid dermal filler with its unique patented
VYCROSS technology, which lasts for up to nine months. In another instance, in
September 2018, Allergan acquired Bonti, Inc. to expand its product portfolio
with Bonti’s pipeline products such as (BoNT/E) botulinum neurotoxin serotype E
in phase II, EB-001T (therapeutic), and EB-001A (aesthetic).
In
depth research report on Hyaluronic Acid Based Dermal Fillers Market
Further key findings from the report suggest:
·
Increase in per capita income in countries such as Germany,
Italy, France, and Spain is a key factor driving the adoption of dermal
fillers. Rapid advancements in dermal filler technology have resulted in better
results in lesser time and at lower costs
·
In 2018, single-phase products dominated the market owing to
technological advancements, wide range of applications, and rise in
applications of implantable devices
·
By application, the wrinkle removal segment is anticipated to
grow at the fastest rate during the forecast period. Hyaluronic acid dermal
fillers are gaining popularity in varied antiaging treatments as they help save
time. A general hyaluronic acid anti-wrinkle treatment procedure takes less
than an hour and the average cost is approximately USD 600
·
Italy dominated the regional market in 2018 owing to
technological advancements in the region and introduction of new products by
prominent manufacturers
·
Some of the key players in this industry are Allergan; Galderma
Laboratories; Merz Pharma; Genzyme Corporation; Medicis Pharmaceutical; Inamed
Corporation; Anika Therapeutics, Inc.; Laboratoires VIVACY; Bioxis
Pharmaceuticals; and Bohus Biotech AB.
Grand View Research
has segmented the Europe hyaluronic acid based dermal fillers market based on
product, application, and region:
Europe Hyaluronic Acid Based Dermal Fillers Product (Revenue,
USD Million, 2015 - 2026)
·
Single-phase Products
·
Duplex Products
Europe Hyaluronic Acid Based Dermal Fillers Application
Outlook (Revenue, USD Million, 2015 - 2026)
·
Wrinkle Removal
·
Lip Augmentation
·
Rhinoplasty
·
Others
Browse
more research reports of this category:
About
Grand View Research
Grand View Research, Inc. is the
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment